Lux Health Tech Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LUXA research report →
About the company
Lux Health Tech Acquisition Corp. currently does not engage in significant operational activities. Instead, its primary focus lies in executing a business combination, such as a merger, a capital stock exchange, an asset acquisition, a stock purchase, or a reorganization, with one or more existing enterprises.
- IPO
- 2020
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $0
- P/E
- 7.85
- P/S
- 0.00
- P/B
- -15.77
- EV/EBITDA
- -0.02
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 36.15%
- ROIC
- -0.34%
- Revenue
- $0 · 0.00%
- Net Income
- $55.38M · 22703.27%
- EPS
- $1.28 · 22556.14%
- Op Income
- $-1,183,000
- FCF YoY
- 99.88%
- 52W High
- $10.12
- 52W Low
- $9.75
- 50D MA
- $10.01
- 200D MA
- $9.91
- Beta
- 0.00
- Avg Volume
- 203.47K
Get TickerSpark's AI analysis on LUXA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 20 | MOLL FREDERIC H | other | 40,000 |
| Oct 26, 20 | DeFonzo Joshua | other | 0 |
Our LUXA coverage
Recent articles, reports, and earnings notes.
No research on LUXA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LUXA report →Similar companies
Peers in the same neighborhood.